Details for Patent: 8,337,824
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,337,824 protect, and when does it expire?
Patent 8,337,824 protects VELTASSA and is included in one NDA.
This patent has seventy-two patent family members in twenty-five countries.
Summary for Patent: 8,337,824
Title: | Linear polyol stabilized polyfluoroacrylate compositions |
Abstract: | The present invention is directed to compositions of a linear polyol and a salt of a crosslinked cation exchange polymer comprising a fluoro group and an acid group. These compositions are useful to bind potassium in the gastrointestinal tract. |
Inventor(s): | Albrecht; Detlef (Saratoga, CA), Burdick; Michael (Los Altos, CA), Chang; Han-Ting (Livermore, CA), Charmot; Dominique (Campbell, CA), Chidambaram; Ramakrishnan (Pleasanton, CA), Connor; Eric (Los Gatos, CA), Halfon; Sherin (Palo Alto, CA), Huang; I-Zu (Mountain View, CA), Liu; Mingjun (Campbell, CA), Mills; Jonathan (San Jose, CA), Struver; Werner (Leverkusen, DE) |
Assignee: | Relypsa, Inc. (Santa Clara, CA) |
Application Number: | 12/545,810 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,337,824 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Use; |
Drugs Protected by US Patent 8,337,824
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-001 | Oct 21, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATMENT OF HYPERKALEMIA | See Plans and Pricing | |||
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-002 | Oct 21, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATMENT OF HYPERKALEMIA | See Plans and Pricing | |||
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATMENT OF HYPERKALEMIA | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,337,824
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2009282721 | See Plans and Pricing | |||
Brazil | PI0917853 | See Plans and Pricing | |||
Canada | 2735058 | See Plans and Pricing | |||
China | 102202670 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |